Actavis Pty Ltd v Orion Corporation (No 2) [2016] FCAFC 159
The respondents were overall successful on the appeal because the major construction and fair basis issues were resolved in their favour and the patent remained valid and infringed as to claims 19 to 22, while the appellants' successful issues concerning claims 17 and 18 and Novartis Australia's standing were relatively limited. The proper balance was therefore to vary the first instance orders to remove claims 17 and 18 and to reflect Novartis Australia's lack of standing, order the appellants to pay 80% of the respondents' appeal costs, and reduce the first instance costs payable to 60%.
- Jurisdiction
- Australia
- Judgment Date
- 23 November 2016
- Procedural Posture
- Appeal Concerning Patent Infringement Orders and Costs / Determined on the Papers After the Appeal Succeeded in Part
- Outcome
- Appeal allowed in part; first instance orders varied or set aside in part; costs apportioned.
- Legal Topics
- ['apportionment of Costs Where Appeal Succeeds in Part' 'variation of Patent Infringement Declarations and Injunctions' 'standing to Sue for Patent Infringement' 'threatened Infringement of Australian Patent No. 765932']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Appeal Concerning Patent Infringement Orders and Costs / Determined on the Papers After the Appeal Succeeded in Part
Legal Issues
- 1 ["What orders should be made to give effect to the Court's reasons allowing the appeal in part." 'What order should be made for the costs of the appeal.' 'What order should be made for the costs of the proceeding below after findings that claims 17 and 18 were not infringed and Novartis Australia lacked standing to sue for infringement.']
Ratio Decidendi
The respondents were overall successful on the appeal because the major construction and fair basis issues were resolved in their favour and the patent remained valid and infringed as to claims 19 to 22, while the appellants' successful issues concerning claims 17 and 18 and Novartis Australia's standing were relatively limited. The proper balance was therefore to vary the first instance orders to remove claims 17 and 18 and to reflect Novartis Australia's lack of standing, order the appellants to pay 80% of the respondents' appeal costs, and reduce the first instance costs payable to 60%.
Court Disposition
Appeal allowed in part; first instance orders varied or set aside in part; costs apportioned.
Orders
- ['The appeal be allowed in part.' 'The orders made on 16 September 2015 in NSD 2456 of 2013 be varied by deleting references to claims 17 and 18 from the declaration, injunction and Attachment A, so that relief concerns claims 19, 20, 21 and 22 insofar as dependent on claims 19 to 21 of Australian Patent No....
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment